Yatırımcı.AI

USUSDSep 28, 23:23

Novo Nordisk A/S

Novo Nordisk A/S NVO

USD 38.71−0.09 (−0.23%)

About TRY 1,896.80 · converted at USD/TRY 49.0003, September 29, 2026, 14:34

Volume
11.3M
Day range
38.23 – 38.90
Previous close
38.80
Market cap
USD 170.9B

Key Data

USD 170.9B
9.70
USD 3.99
52 weeks
35.2963.98
Day range
38.2338.90
1-year return
−34.10%
Previous close
38.80
Open
38.40
11.3M
Avg. volume (200d)
17.1M
Sector
Healthcare
Industry
Drug Manufacturers - General

Technical Signals

Technical signals

Only our Plus members can access this area.

AI Models

AI models

Only our Plus members can access this area.

About Novo Nordisk A/S

Novo Nordisk A/S (NVO) last traded at 38.71 USD on the US stock market, a daily move of −0.23%. Converted at the USD/TRY rate of 49.0003 as of September 29, 2026, 14:34, this price equals about TRY 1,896.80; the conversion is for information only and the rate a broker applies may differ. Market capitalization is 170.9B USD, earnings per share 3.99 USD, the price-to-earnings ratio 9.70 and the dividend yield 4.64%. The company operates in the Healthcare sector, within the Drug Manufacturers - General industry. The 52-week range is 35.29 – 63.98 USD; the one-year return is −34.10%.

Frequently Asked Questions

Novo Nordisk A/S (NVO) last traded at 38.71 USD, a daily change of −0.23%. Prices are delayed by at least 15 minutes.

The last price of Novo Nordisk A/S (NVO) is USD 38.71. Converted at the USD/TRY rate of 49.0003 as of September 29, 2026, 14:34, that is about TRY 1,896.80. The conversion is for information only; trades use the exchange rate and fees your broker applies.

US stocks such as Novo Nordisk A/S (NVO) can be bought through Turkish brokerage firms (aracı kurumlar) that offer access to foreign markets. You open an account enabled for foreign equity trading; because US stocks trade in dollars, the account and trades are in USD, so lira savings are converted to dollars first. The regular session on the NYSE and Nasdaq runs from 09:30 to 16:00 New York time, which is 16:30–23:00 Türkiye time while US daylight saving time is in effect and 17:30–00:00 otherwise. Taxation is subject to Turkish tax law; check the Revenue Administration (GİB) for current rules.

NVO trades at a price-to-earnings ratio of 9.70, with earnings per share of 3.99 USD and a market capitalization of 170.9B USD. Ratios use the latest reported results and the current price.

Over the past 52 weeks NVO traded between 35.29 and 63.98 USD; the one-year return is −34.10%.

The current dividend yield of NVO is 4.64%. Dividend yield is the annual cash dividend divided by the share price; the company may change its policy.

Novo Nordisk A/S (NVO) is listed on the US stock market; its sector is Healthcare and its industry is Drug Manufacturers - General.

Prices, volume and fundamentals come from licensed data providers; prices are delayed by at least 15 minutes and fundamentals refresh daily. AI forecasts are generated by Yatırımcı.AI models and are not investment advice.